Asia-Pacific Leukemia Consortium

The establishment of Asia-Pacific Leukemia Consortium (APLC) on the 8th of Sept 2021 serves as a platform to facilitate greater collaboration across the Asia-Pacific region for different stakeholders:

• Clinicians
  
• Researchers
• Healthcare professionals
• Industry partners

Mission Statement

To improve the management of Leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.

The Opportunity

Establishing value partnerships within the ecosystem of clinicians, researchers, healthcare providers and Bio-pharmaceutical industry to maximize resources and accelerate improve in patient care.

Focus Areas

• Clinical trials
• Real-world Disease Registry and Genetic & Tissue Repository
• Education
• Patient advocacy

Working Groups

• Myeloid Working Group
• Lymphoid Working Group
• Real-World Disease Registry Working Group

Current members' countries/regions include Australia, China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand.

Contact Information

Asia-Pacific Leukemia Consortium

Main Office
Asia-Pacific Leukemia Consortium (APLC) c/o Singapore General Hospital Pte Ltd
10 Hospital Boulevard #19-01 Singapore 168582

Email:
Lynn.wong.b.l@sgh.com.sg
Lowen+APLC@beyondkairossg.com

Website:
https://www.aplcon.org